Precision Health Research, Singapore (PRECISE), and AI & digital transformation company, Temus, have signed a memorandum of understanding to establish a PRECISE-Temus Joint Innovation Centre (JIC). This five-year collaboration aims to support the technology, data, and delivery capabilities for Phase III of Singapore's National Precision Medicine (NPM) programme. The signing took place at the Precision Health Partnerships in Singapore event, witnessed by Mr Ong Ye Kung, Minister for Health and Coordinating Minister for Social Policies.
The JIC brings together PRECISE's leadership of Singapore's national precision medicine programme with Temus's vision-to-value approach to transformation. It will help translate precision medicine from research into practical applications by strengthening the digital infrastructure, operating models, and safeguards needed to manage genomic data securely and responsibly. This partnership builds on work that PRECISE and Temus have undertaken together since 2024.
NPM's Phase III, launched in November 2025, aims to sequence the genomes of about 10 per cent of Singapore's local resident population (450,000 residents) and build evidence on how genomic information can be used responsibly in healthcare at population scale. Professor Patrick Tan, Executive Director of PRECISE, stated that Phase III is not simply about sequencing more genomes, but about ensuring that NPM Phase III can manage genomic data securely and responsibly.
The JIC plans to build a secure genomics data infrastructure that handles around 13.6 petabytes of genomic data, scaling to more than 60 petabytes, and cutting data-processing timelines from weeks to days. The work spans data pipelines, research platforms, and visualisation solutions. Scientists and engineers will work together to develop shared platforms for processing and analysing whole-genome data efficiently, sustainably, and securely.
The centre will also help ensure that these platforms can be maintained and improved as programme needs evolve, rather than rebuilt for each new project. The team will establish structured processes and appropriate safeguards to assess and integrate emerging methodologies and technologies, including AI-enabled tools. Sng Ren Yeong, Chief Executive Officer of Temus, emphasized that precision health is a powerful example of why technology alone is not the solution.
The JIC is expected to build specialist delivery capability development across Singapore's precision health ecosystem. Temus plans to explore talent development pathways for specialist consultants and engineers in areas such as computational biology and bioinformatics specific to precision medicine and genomics. These specialists would work alongside research and technology teams to build practical expertise through live projects.
For Temus, the JIC also represents a significant healthcare application of its AI Foundry, one of the priority sectors under Singapore's National AI Impact Programme. Launched in May 2026, the AI Foundry is hiring, developing, and deploying 50 Singapore-based AI professionals in live enterprise projects, building production-grade AI assets, data pipelines, governance frameworks, and human-in-the-loop systems for regulated and operationally complex environments.
Key points
- PRECISE and Temus partner to advance Singapore's National Precision Medicine programme through a five-year Joint Innovation Centre collaboration.
- The JIC aims to build a secure genomics data infrastructure and develop specialist delivery capability across Singapore's precision health ecosystem.
- The partnership represents a significant healthcare application of Temus's AI Foundry, supporting Singapore's National AI Impact Programme.
